About: Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2002

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2002 (uk) im April 2002 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 2002 (ast) scientific article published on 01 April 2002 (en)
publication date	wds:Q56967600-F1BEA0A6-5797-4EE5-82E4-24B6CFA3905C
publication date	2002-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56967600-74365106-D6B0-4C32-9000-922A5863CF52
language of work or name	English
cites work	wds:Q56967600-02AA2332-EE89-4CF4-BF7C-26F89D87C4D2 wds:Q56967600-03D4B625-30C2-4B28-A803-E04274E8A3FB wds:Q56967600-0A13AAD1-5AC4-4A9C-A7A4-29AA4A9A5281 wds:Q56967600-0DA08FEA-2E47-4904-B923-286376490A50 wds:Q56967600-25968BB9-EE95-4222-8879-96AA6FB94BA7 wds:Q56967600-29C80966-6DFE-4B52-8502-D63337BA99C0 wds:Q56967600-4675FBE8-6CFD-4645-A10D-EFA6C0B8F68E wds:Q56967600-469E1761-03A6-42C1-B237-666343730B62 wds:Q56967600-58A107E0-C3C0-4D45-A7C7-F00517C2B41A wds:Q56967600-5CD1EDAA-5180-4A0A-A830-DCF23BC9D657 wds:Q56967600-5E6D53DC-B8B7-4860-9FD5-A5C620DBFC33 wds:Q56967600-6E2D4532-A08C-403A-B95E-D9B301B309BE wds:Q56967600-711B70F5-2FD2-436F-BFEB-34BA304D1947 wds:Q56967600-71C563C7-3838-4873-BB17-65D4065B6525 wds:Q56967600-908829FA-3D99-4C93-9925-E9D9584F7A74 wds:Q56967600-AA2FC125-F6FB-4279-9FEE-B2DAEE14CAD3 wds:Q56967600-ACE83954-6141-4207-BE4B-7D2852F0C922 wds:Q56967600-AD849A22-9C7B-4196-A7CA-C96A21F0FA8D wds:Q56967600-AFBC5691-F5F7-442D-8995-431DE6B34579 wds:Q56967600-B81DFAE1-9189-480D-B09B-7DEA86F5FC8A wds:Q56967600-BF5AC6BE-BE5E-42E1-BDEA-26EE7EE04449 wds:Q56967600-CF9B39F3-FBF8-4B6C-AC2A-8B47AE7C2018 wds:Q56967600-DB321DAB-76E8-4BA5-8A36-17E364031337 wds:Q56967600-E667B121-6EA3-43E7-97B9-3C2354D46B97 wds:Q56967600-E6EAE1D0-003B-4CEC-A1BB-6671BE514870 wds:Q56967600-E91E3E31-9C14-43AD-A647-D3BF5D0BBE49 wds:Q56967600-EA2DBDA4-43E9-4983-9A50-CF572D99B2AA wds:Q56967600-EB75C27A-BA03-419A-AB18-ACB84CF81321 wds:Q56967600-FA9E8AE5-8093-424B-BA05-ACF8C42FCB5C
cites work	Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Dendritic cells and the control of immunity Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Antigen processing and presentation by the class I major histocompatibility complex Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine Green fluorescent protein as a marker for gene expression Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen Proliferating dendritic cell progenitors in human blood Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy. Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Induction of antitumor immunity using bone marrow-generated dendritic cells New opportunities for the development of cancer immunotherapies. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides Tumour immunotherapy: the adjuvant treatment of the 21st century?
author name string	wds:Q56967600-1DFE1F08-7E93-4683-8DF4-D740B9D49859 wds:Q56967600-913A2146-C2BE-4F57-803A-846D107D2E65 wds:Q56967600-A886A451-6424-4FD9-96C8-C3E46186D1E6 wds:Q56967600-E726169E-D919-46B5-ACE0-1868A32163E5 wds:Q56967600-F4A8B5E0-A3D4-463E-8EBA-6A68AFB27062
author name string	Michael Morse David Boczkowski Eli Gilboa Smita K Nair R Ian Cumming
rdfs:label	Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells (en) Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells (nl)
skos:prefLabel	Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells (en) Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells (nl)
name	Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells (en) Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells (nl)
author	wds:Q56967600-87016AE8-E163-4101-BCA9-F5112F2696E3 wds:Q56967600-BA50DF37-27F7-4D2F-A75D-7090240F88FD
author	Herbert Kim Lyerly Ljiljana Vasovic
title	wds:Q56967600-3064B7DB-B306-4BD3-B64C-51BD4DA16AA5
title	Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells (en)
page(s)	wds:Q56967600-814FF821-A828-49D6-B7F9-7918D94AE536
page(s)	540-549
instance of	wds:Q56967600-E0EA6CAC-899A-49AF-BD8A-550AA6C3AF5A
instance of	scholarly article
main subject	wds:Q56967600-09134BBF-69A8-424C-9F25-FDA27D4A7860 wds:Q56967600-09C1551B-B287-4F97-AEBA-94FBDBE02808 wds:Q56967600-D015FC11-C729-464D-97FD-C76BC230355E
main subject	cytotoxicity Patients dendritic cell

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software